FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Jan 9, 2026
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on January 9, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · f0526daf-6fb3-469d-a2ec-0654e22b33cc
Inspection Facts
- Inspection number
- 1297970
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 640.4(f)Arm preparation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneBlood, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 22, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 31, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 18, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 15, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1170316 - 2022-05-16
- FDA Inspection 1067954 - 2018-06-22
- FDA Inspection 966465 - 2016-03-31
- FDA Inspection 895927 - 2014-09-18
- FDA Inspection 783005 - 2012-05-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.